CARDIUM THERAPEUTICS Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Cardium Therapeutics

Access the complete profile.

Cardium Therapeutics Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	32541
Address	11750 Sorrento Valley Road Suite 250 San Diego, CA 92121 cardiumthx.com

Note: Revenues for privately held companies are statistical evaluations.




Cardium Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
• What industry is the company in?

Cardium Therapeutics Annual Revenue and Growth Rate

Cardium Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2020	Details in Premium Report
2019
2018
2017
2016

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Cardium Therapeutics's revenues are gauged from an analysis of company filings.

Investor Activity

Cardium Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
June 23, 2009	8	100%	$1 MM
Complete list of funding rounds and total amounts in the Company Report

Cardium Therapeutics's Income Statement (based on Industry Averages)

	$ Millions (Industry Average)
Cardium Therapeutics Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Cardium Therapeutics is developing and marketing. Cardium Therapeutics doesn't have any recent trademark applications, indicating Cardium Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ACTIVATION THERAPEUTICS Pharmaceuticals for wound healing or orthopedic bone, ligament, tendon and cartilage regeneration; biologics, namely, pharmaceutical preparations for wound healing or orthopedic bone, ligament, tendon and cartilage regeneration; pharmaceutical products and preparations comprising DNA and protein for wound healing, orthopedic bone, ligament, tendon and cartilage regeneration; pharmaceutical hydrogels comprising a biologic, namely, collagen, viral vectors, or growth factors, for wound healing, orthopedic bone, ligament, tendon and cartilage regeneration	06/21/2013
BRAIN SECURE Dietary and nutritional supplements; Multi-vitamin preparations; Nutraceuticals for use as a dietary supplement; Vitamin and mineral supplements; Vitamin B preparations	05/30/2013
E-QUATION data analytics, medical data analytics	04/15/2013

See all trademarks and details in the Full Report.

Recession Risk

Determine whether Cardium Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Cardium Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.

Market Share of Cardium Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cardium Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
NUTRITION FORMULATORS	Miramar, FL	96
UCKELE HEALTH & NUTRITION	Blissfield, MI	57
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
VITALABS	Mcdonough, GA	37
RTPR	Edmond, OK	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28

Nearby Competitors

These companies are similar in business line and location to Cardium Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CARDIUM THERAPEUTICS	San Diego, CA	100
GEN-PROBE	San Diego, CA	0
AJINOMOTO ALTHEA	San Diego, CA	0
TURNING POINT THERAPEUTICS	San Diego, CA	0
ODONATE THERAPEUTICS	San Diego, CA	0
IRISYS	San Diego, CA	0

Future Competition: Cardium Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Cardium Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)